• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Antitumor Drugs

Russian antitumor drugs first time received a registration certificate in Europe
March 31, 2020
Pharmaceutical News

Russian antitumor drugs first time received a registration certificate in Europe

Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of ICM d.o.o partner and is valid for 5 years. The first deliveries shall start in June 2020.

More
Russian antitumor drugs first time received a registration certificate in Europe
Pharmaceutical News

Russian antitumor drugs first time received a registration certificate in Europe

March 31, 2020

Two BIOCAD products, Acellbia (INN: rituximab) and Herticad (INN: trastuzumab), received the first European registration certificate in Bosnia and Herzegovina.

More
  • The Benefits of a Career as a Pharmacy Technician
  • Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
  • CPHI China opens for international partnering after China rises in CPHI Index
  • Azelis inaugurates state-of-the-art Regional Innovation Center for Food & Nutrition in Singapore 
  • Why Consider a Career as a Pharmacy Technician?

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop